share_log

HC Wainwright & Co. Maintains Buy on Axsome Therapeutics, Maintains $190 Price Target

HC Wainwright & Co. Maintains Buy on Axsome Therapeutics, Maintains $190 Price Target

HC Wainwright & Co.维持对Axsome Therapeutics的买入,维持190美元的目标股价
Moomoo 24/7 ·  04/02 08:53

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Axsome Therapeutics (NASDAQ:AXSM) with a Buy and maintains $190 price target.

HC Wainwright & Co. 分析师拉古拉姆·塞尔瓦拉朱维持Axsome Therapeutics(纳斯达克股票代码:AXSM)的买入并维持190美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发